58 related articles for article (PubMed ID: 10690183)
1. Different incidence of loss of heterozygosity on chromosome 16q between intraductal papilloma and intracystic papillary carcinoma of the breast.
Tsuda H; Uei Y; Fukutomi T; Hirohashi S
Jpn J Cancer Res; 1994 Oct; 85(10):992-6. PubMed ID: 7961109
[TBL] [Abstract][Full Text] [Related]
2. CD44 expression in intraoral salivary ductal papillomas and oral papillary squamous cell carcinoma.
Fitzpatrick SG; Montague LJ; Cohen DM; Bhattacharyya I
Head Neck Pathol; 2013 Jun; 7(2):122-8. PubMed ID: 23143465
[TBL] [Abstract][Full Text] [Related]
3. Papillary lesions of the breast diagnosed using core needle biopsies.
Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
Exp Ther Med; 2011 Nov; 2(6):1069-1072. PubMed ID: 22977622
[TBL] [Abstract][Full Text] [Related]
4. High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study.
Gao Y; Liu Z; Gao F; Meng XY
BMC Cancer; 2010 Apr; 10():131. PubMed ID: 20374665
[TBL] [Abstract][Full Text] [Related]
5. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
[TBL] [Abstract][Full Text] [Related]
6. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
Liu YJ; Yan PS; Li J; Jia JF
World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
[TBL] [Abstract][Full Text] [Related]
7. Papillary lesions of the breast: selected diagnostic and management issues.
Collins LC; Schnitt SJ
Histopathology; 2008 Jan; 52(1):20-9. PubMed ID: 18171414
[TBL] [Abstract][Full Text] [Related]
8. Papillary lesions of the breast: imaging findings and diagnostic challenges.
Jagmohan P; Pool FJ; Putti TC; Wong J
Diagn Interv Radiol; 2013; 19(6):471-8. PubMed ID: 23996839
[TBL] [Abstract][Full Text] [Related]
9. CD44s as a surrogate marker for distinguishing intraductal papilloma from papillary carcinoma of the breast.
Saddik M; Lai R
J Clin Pathol; 1999 Nov; 52(11):862-4. PubMed ID: 10690183
[TBL] [Abstract][Full Text] [Related]
10. CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast.
Tse GM; Tan PH; Ma TK; Gilks CB; Poon CS; Law BK
J Clin Pathol; 2005 Nov; 58(11):1185-8. PubMed ID: 16254109
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical staining of papillary breast lesions.
Troxell ML; Masek M; Sibley RK
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):145-53. PubMed ID: 17525625
[TBL] [Abstract][Full Text] [Related]
12. Differential CD133 expression distinguishes malignant from benign papillary lesions of the breast.
Lin CH; Liu CH; Wen CH; Ko PL; Chai CY
Virchows Arch; 2015 Feb; 466(2):177-84. PubMed ID: 25433813
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic and immunohistochemical study of 187 cases of intraductal papillary neoplasm of breast].
Zhang H; Xiong Y; Zhang S; Zhang Y; Wang YH; Li T
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):726-31. PubMed ID: 22336153
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ?
Tan PH; Aw MY; Yip G; Bay BH; Sii LH; Murugaya S; Tse GM
Am J Surg Pathol; 2005 May; 29(5):625-32. PubMed ID: 15832086
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
